Kestra Medical Technologies, Ltd. (KMTS)

KMTS Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2023	FY 2020	FY 2019
Period Ending	Jan 31, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2021	Apr 30, 2020
Cash & Equivalents	291.32	237.6	8.25	24.34	5.76
Cash & Short-Term Investments	291.32	237.6	8.25	24.34	5.76
Cash Growth	435.99%	2780.29%	-66.11%	322.90%	-
Accounts Receivable	12.71	8.08	2	-	-
Inventory	6.83	6.57	3.29	-	-
Other Current Assets	3.2	3.08	1.37	1.85	0.41
Total Current Assets	314.06	255.33	14.91	26.2	6.17
Net Property, Plant & Equipment	57.22	36.91	28.39	3.08	1.13
Other Long-Term Assets	8.06	3.51	2.65	1.24	0.58
Total Assets	379.34	295.74	45.95	30.52	7.87
Accounts Payable	24.02	23.96	23.89	1.7	1.83
Accrued Expenses	18.9	13.83	9.08	3.85	1.73
Current Portion of Leases	0.01	0.19	-	1.06	0.45
Total Current Liabilities	42.93	37.98	32.97	6.61	4.02
Long-Term Debt	42.26	41.1	42.54	20.24	-
Long-Term Leases	4.28	3.03	2.63	1.55	-
Other Long-Term Liabilities	1.89	8.24	0.08	0.36	-
Total Long-Term Liabilities	48.42	52.36	45.25	22.15	-
Total Liabilities	91.35	90.34	78.22	28.76	4.02
Common Stock	58.35	51.35	19.91	0	0
Additional Paid-in Capital	842.67	674.31	177.15	171.85	139.84
Retained Earnings	-613.03	-520.25	-406.44	-170.08	-135.98
Total Common Shareholders' Equity	287.99	205.41	-209.38	1.77	3.86
Minority Interest	-	-	177.11	-	-
Shareholders' Equity	287.99	205.41	177.11	1.77	3.86
Total Liabilities & Equity	379.34	295.74	45.95	30.52	7.87
Total Debt	46.55	44.31	45.17	22.85	0.45
Net Cash (Debt)	244.77	193.28	-36.92	1.49	5.3
Net Cash Growth	26.64%	-	-	-71.85%	-
Net Cash Per Share	5.35	7.86	-1.86	-	-
Book Value	287.99	205.41	-209.38	1.77	3.86
Book Value Per Share	6.29	8.36	-10.53	-	-
Tangible Book Value	287.99	205.41	-209.38	1.77	3.86
Tangible Book Value Per Share	6.29	8.36	-10.53	-	-

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q